Tofacitinib alleviated salivary gland inflammation and reduced the percentages of effector T cells in murine Sjögren's disease
Our data indicated that tofacitinib reduced percentages of effector T cells in an animal model of SjD. In addition, tofacitinib alleviated salivary gland inflammation and hypofunction, offering new insights into the clinical management of SjD.
Authors
- Qinghong Liu (ORCID: https://orcid.org/0009-0008-1643-4344)
- Jing He (ORCID: https://orcid.org/0000-0002-1954-2892)
- Xiaoyan Xing
Institutions
- Peking University (CN)
- Peking University People's Hospital (CN)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2024-09-30
- DOI
- https://doi.org/10.55563/clinexprheumatol/b91fx8
- Citations
- 4
- Primary Topic
- Salivary Gland Disorders and Functions
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- National Natural Science Foundation of China
- Beijing Nova Program